BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 26224102)

  • 1. Gut microorganisms as promising targets for the management of type 2 diabetes.
    Delzenne NM; Cani PD; Everard A; Neyrinck AM; Bindels LB
    Diabetologia; 2015 Oct; 58(10):2206-17. PubMed ID: 26224102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies.
    Woldeamlak B; Yirdaw K; Biadgo B
    Korean J Gastroenterol; 2019 Dec; 74(6):314-320. PubMed ID: 31870137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders.
    Neyrinck AM; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):722-8. PubMed ID: 20823777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes, obesity and gut microbiota.
    Everard A; Cani PD
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):73-83. PubMed ID: 23768554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting.
    Genton L; Cani PD; Schrenzel J
    Clin Nutr; 2015 Jun; 34(3):341-9. PubMed ID: 25459400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet, gut microbiota and cognition.
    Proctor C; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2017 Feb; 32(1):1-17. PubMed ID: 27709426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Brunkwall L; Orho-Melander M
    Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
    Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
    Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in common elderly diseases affecting activities of daily living.
    Shimizu Y
    World J Gastroenterol; 2018 Nov; 24(42):4750-4758. PubMed ID: 30479462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and obesity: lessons from the microbiome.
    Cani PD
    Brief Funct Genomics; 2013 Jul; 12(4):381-7. PubMed ID: 23616309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome and Gut Dysbiosis.
    Belizário JE; Faintuch J
    Exp Suppl; 2018; 109():459-476. PubMed ID: 30535609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics.
    Rodriguez J; Delzenne NM
    J Endocrinol; 2021 Apr; 249(1):R1-R23. PubMed ID: 33502337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.